610 filings
10-K
2023 FY
REGN
Regeneron Pharmaceuticals, Inc.
Annual report
5 Feb 24
9:16am
8-K
REGN
Regeneron Pharmaceuticals, Inc.
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
8-K
REGN
Regeneron Pharmaceuticals, Inc.
31 Jan 24
Departure of Directors or Certain Officers
4:17pm
8-K
REGN
Regeneron Pharmaceuticals, Inc.
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
cqyamlpj ljcaeo
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
8-K
mhc l9sljh9
5 Oct 23
Results of Operations and Financial Condition
4:04pm
SC TO-T/A
a2thdl7mkt10l2g
25 Sep 23
Third party tender offer statement (amended)
8:48am
SC TO-T/A
9ft02yj77 qc25
12 Sep 23
Third party tender offer statement (amended)
4:38pm
8-K/A
uf8 51lt7aod95d
8 Sep 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
skv qobif
8 Sep 23
Departure of Directors or Certain Officers
4:52pm
SC TO-T/A
nyo moyasp
8 Sep 23
Third party tender offer statement (amended)
4:05pm
SC TO-T
zs7wfg33mua x2u
25 Aug 23
Third party tender offer statement
7:46am
SC TO-C
l6ku5kr
9 Aug 23
Information about tender offer
4:15pm
8-K
81vyy fam7
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
8-K
dt0gb0axsqy0cd
14 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:07pm
PX14A6G
zdddbb
18 May 23
Letter to shareholders
4:46pm
DEFA14A
vzfcg0u kl8jw9
17 May 23
Additional proxy soliciting materials
4:04pm